Inventor · disambiguated record
Elzbieta Izbicka
Also filed as: IZBICKA ELZBIETA
13 granted patents·8 pending applications·193 citations·filing 1994–2021
91Inventor score
Files withCANCER PREVENTION & CURE LTD5NEW FRONTIER LABS LLC5STREEPER ROBERT T3MICHALEK JOEL2RHONE POULENC RORER PHARMA2
Top patents by PatentIndex Score
21 records- 0189US5656598AUse of fibroblast growth factors to stimulate bone growthRHONE POULENC RORER PHARMA·Filed 1995·Granted Aug 12, 1997·89 cites·37 claims
- 0287US11918555B2Dicarboxylic acid esters for the treatment of diseases and conditions associated with phospholipase D toxinNEW FRONTIER LABS LLC·Filed 2021·Granted Mar 5, 2024·1 cites·12 claims
- 0387US11911358B2Dicarboxylic acid esters for inducing an analgesic effectNEW FRONTIER LABS LLC·Filed 2021·Granted Feb 27, 2024·1 cites·11 claims
- 0486US11026912B2Azelaic acid esters in the treatment of insulin resistanceNEW FRONTIER LABS LLC·Filed 2019·Granted Jun 8, 2021·2 cites·13 claims
- 0585US10251857B2Azelaic acid esters in the treatment of insulin resistanceNEW FRONTIER LABS LLC·Filed 2017·Granted Apr 9, 2019·5 cites·19 claims
- 0681US5614496AUse of fibroblast growth factors to stimulate bone growthOSTEOSA INC·Filed 1995·Granted Mar 25, 1997·59 cites·17 claims
- 0777US9933429B2Methods of identification, assessment, prevention and therapy of lung diseases and kits thereofBAEK SUNG H·Filed 2010·Granted Apr 3, 2018·4 cites·8 claims
- 0877US7888051B2Method of identifying biomarkers in human serum indicative of pathologies of human lung tissuesCANCER PREVENTION & CURE LTD·Filed 2008·Granted Feb 15, 2011·8 cites·34 claims
- 0976US8541183B2Methods of identification, assessment, prevention and therapy of lung diseases and kits thereofSTREEPER ROBERT T·Filed 2009·Granted Sep 24, 2013·6 cites·28 claims
- 1075US9952220B2Methods of identification and diagnosis of lung diseases using classification systems and kits thereofMICHALEK JOEL·Filed 2012·Granted Apr 24, 2018·6 cites·10 claims
- 1171US12329735B2Azelaic acid esters in the treatment of insulin resistanceNEW FRONTIER LABS LLC·Filed 2021·Granted Jun 17, 2025·0 cites·17 claims
- 1261US2009326069A1Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkersBLTN LLC·Filed 2009·Application pending·0 cites
- 1357US2015126403A1Method of identifying proteins in human serum indicative of pathologies of human lung tissuesCANCER PREVENTION & CURE LTD·Filed 2014·Application pending·0 cites
- 1456US11474104B2Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapyCANCER PREVENTION & CURE LTD·Filed 2018·Granted Oct 18, 2022·0 cites·16 claims
- 1556US2018088126A1Method of identifying proteins in human serum indicative of pathologies of human lung tissuesCANCER PREVENTION & CURE LTD·Filed 2017·Application pending·0 cites
- 1653US5408041AProcess of purifying antler-derived bone growth factorsRHONE POULENC RORER PHARMA·Filed 1994·Granted Apr 18, 1995·12 cites·3 claims
- 1753US2009069189A1Method of identifying proteins in human serum indicative of pathologies of human lung tissuesCANCER PREVENTION & CURE LTD·Filed 2008·Application pending·0 cites
- 1848US2019072554A1Methods of Identification and Diagnosis of Lung Diseases Using Classification Systems and Kits ThereofMICHALEK JOEL·Filed 2018·Application pending·0 cites
- 1947US2015299803A1Methods of Using Biomarkers for the Treatment of Cancer by Modulation of BCL2 ExpressionPRONAI THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2045US2014094516A1Method of utilizing azelaic acid esters to modulate communications mediated by biological moleculesSTREEPER ROBERT T·Filed 2013·Application pending·0 cites
- 2142US2012251525A1Method of utilizing azelaic acid esters to modulate communications mediated by biological moleculesSTREEPER ROBERT T·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elzbieta Izbicka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →